Back to search

Article

Beta <sub>2</sub> -Adrenergic Agonists in Treatment for Parkinsonism, with Implications for Neurodegenerative and Neoplastic Disorders

2024-01-17

Abstract excerpt

There is a long record of observations suggesting that β 2 -adrenergic agonists may have therapeutic value in Parkinson’s disease. Recent studies have focused on the possible role of β 2 -receptor agonists in suppressing the formation of α-synuclein protein, the component of Lewy bodies. Levalbuterol, the pure levo isomer of the β2 selective agonist, albuterol, has been found to possess significant anti-inflamma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7489eac9-ff1e-5ad7-9044-116591ee7003
DOI
10.1101/2024.01.12.575406
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Beta <sub>2</sub> -Adrenergic Agonists in Treatment for Parkinsonism, with Implications for Neurodegenerative and Neoplastic DisordersDOI 10.1101/2024.01.12.575406
Inhibition of Human Mantle Cell Lymphomas by the β <sub>2</sub> -Adrenergic Agonist, Levalbuterol, in the Hollow Fiber Assay in MiceSemantic proximity
Further investigation of the potential anti-neoplastic, anti-inflammatory and immunomodulatory actions of phenoxybenzamine using the Broad Institute CLUE platformSemantic proximity
Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicitySemantic proximity
β2 Agonists.Semantic proximity
ScRNA-seq reveals the chronic methamphetamine-induced immunosuppression in murine PBMC with involvement of dopamine receptor D1Semantic proximity
Sympathetic neural signaling via the β2‐adrenergic receptor suppresses T‐cell receptor‐mediated human and mouse CD8<sup>+</sup> T‐cell effector functionSemantic proximity
Synthetic Cannabinoids and the Purinergic–Dopaminergic Axis: P2X7 as a Primary Sensor of Neuroinflammatory Injury and the Role of Adenosine Receptor Heteromers in Emerging NPS ToxicitySemantic proximity
β2-Adrenergic Biased Agonist Nebivolol Inhibits the Development of Th17 and the Response of Memory Th17 Cells in an NF-κB-Dependent MannerSemantic proximity
Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.Semantic proximity
Molecular Mechanisms of Combination Therapy With Inhaled Corticosteroids and Long-Acting β-AgonistsSemantic proximity
Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial Completed.Semantic proximity
5-HT <sub>2B</sub> serotonin receptor agonist BW723C86 shapes the macrophage gene profile via AhR and impairs monocyte-to-osteoclast differentiationSemantic proximity
Select a neighboring publication to make it the new centre.